SILVERARC CAPITAL MANAGEMENT, LLC
Q2 2026 13F filing
Updated 28 days ago73 disclosed positions worth $962.2M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ASND ASCENDIS PHARMA A/S | $55M | 206.2K | 5.72% | — |
| 2 | C CELC CELCUITY INC | $52.4M | 501.0K | 5.45% | — |
| 3 | C COGT COGENT BIOSCIENCES INC | $49.6M | 1.28M | 5.15% | — |
| 4 | U URGN UROGEN PHARMA LTD | $47.9M | 1.30M | 4.98% | — |
| 5 | I IMNM IMMUNOME INC | $42.7M | 2.02M | 4.44% | — |
| 6 | D DNTH DIANTHUS THERAPEUTICS INC | $38M | 390.0K | 3.95% | — |
| 7 | R RYTM RHYTHM PHARMACEUTICALS INC | $34.6M | 311.5K | 3.59% | — |
| 8 | O ORKA ORUKA THERAPEUTICS INC | $33.6M | 352.8K | 3.49% | — |
| 9 | M MNST MONTE ROSA THERAPEUTICS INC | $26.8M | 1.11M | 2.79% | — |
| 10 | S SNDX SYNDAX PHARMACEUTICALS INC | $26.5M | 1.21M | 2.76% | — |
| 11 | E ELVN ENLIVEN THERAPEUTICS INC | $24.8M | 489.4K | 2.58% | — |
| 12 | I IMVT IMMUNOVANT INC | $23.9M | 619.1K | 2.48% | — |
| 13 | E EQR ERASCA INC | $23.1M | 1.26M | 2.40% | — |
| 14 | S SGMT SAGIMET BIOSCIENCES INC | $22.6M | 2.93M | 2.35% | — |
| 15 | A AAVXF ABIVAX SA | $22.6M | 169.6K | 2.35% | — |
| 16 | P PRAX PRAXIS PRECISION MEDICINES I | $22M | 65.7K | 2.29% | — |
| 17 | K KOD KODIAK SCIENCES INC | $21.3M | 546.3K | 2.21% | — |
| 18 | ? N/A ARK ETF TR | $21M | 500.0K | 2.19% | — |
| 19 | D DFTX DEFINIUM THERAPEUTICS INC | $18.8M | 400.0K | 1.96% | — |
| 20 | V VCYT VERACYTE INC | $18.7M | 318.0K | 1.94% | — |
| 21 | S SNDX SYNDAX PHARMACEUTICALS INC | $15.2M | 693.6K | 1.58% | — |
| 22 | G GH GUARDANT HEALTH INC | $15M | 99.8K | 1.56% | — |
| 23 | B BEPC C4 THERAPEUTICS INC | $14.2M | 3.03M | 1.47% | — |
| 24 | Z ZBIO ZENAS BIOPHARMA INC | $12.9M | 509.8K | 1.34% | — |
| 25 | T TRVI TREVI THERAPEUTICS INC | $12.6M | 678.1K | 1.31% | — |
| 26 | ? N/A HELIX ACQUISITION CORP III | $12.5M | 1.18M | 1.30% | — |
| 27 | A ALXO ALX ONCOLOGY HLDGS INC | $11.9M | 5.74M | 1.24% | — |
| 28 | M MANE VERADERMICS INC | $11.7M | 95.0K | 1.21% | — |
| 29 | X XENE XENON PHARMACEUTICALS INC | $11.3M | 186.8K | 1.17% | — |
| 30 | A AVLN AVALYN PHARMACEUTICALS INC | $10.9M | 330.5K | 1.13% | — |
| 31 | B BIIB BIOGEN INC | $10.4M | 48.1K | 1.08% | — |
| 32 | A ACRS ACLARIS THERAPEUTICS INC | $10.3M | 1.95M | 1.07% | — |
| 33 | C CERS CERUS CORP | $10.1M | 3.47M | 1.05% | — |
| 34 | ? N/A AVALO THERAPEUTICS INC | $9.2M | 500.4K | 0.96% | — |
| 35 | B BNTC BENITEC BIOPHARMA INC | $9.1M | 679.8K | 0.95% | — |
| 36 | P PCVX VAXCYTE INC | $8.4M | 145.0K | 0.88% | — |
| 37 | W WGSWW GENEDX HOLDINGS CORP | $8.4M | 122.3K | 0.87% | — |
| 38 | S SVRA SAVARA INC | $8.3M | 1.36M | 0.87% | — |
| 39 | O OVID OVID THERAPEUTICS INC | $8.3M | 3.10M | 0.87% | — |
| 40 | O ORIC ORIC PHARMACEUTICALS INC | $8M | 738.9K | 0.83% | — |
| 41 | ? N/A ORIC PHARMACEUTICALS INC | $7.4M | 682.6K | 0.77% | — |
| 42 | ? N/A MONTE ROSA THERAPEUTICS INC | $7.3M | 300.0K | 0.75% | — |
| 43 | C CMPS COMPASS PATHWAYS PLC | $7.1M | 503.4K | 0.74% | — |
| 44 | C CGEN COMPUGEN LTD | $6.8M | 3.18M | 0.71% | — |
| 45 | S SLDB SOLID BIOSCIENCES INC | $6.7M | 668.5K | 0.69% | — |
| 46 | A AAVXF ABIVAX SA | $6.7M | 50.0K | 0.69% | — |
| 47 | ? N/A IBIO INC | $6.2M | 3.52M | 0.64% | — |
| 48 | I IRON DISC MEDICINE INC | $6.1M | 82.8K | 0.63% | — |
| 49 | A ALKS ALKERMES PLC | $5.9M | 113.5K | 0.62% | — |
| 50 | S SYRE SPYRE THERAPEUTICS INC | $5.3M | 60.0K | 0.55% | — |